联系方式:400-990-3999 / 邮箱:sales@xiyashiji.com
西亚试剂 —— 品质可靠,值得信赖
Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38
Xiaochun Bai,1,3 Dongzhu Ma,1 Anling Liu,1 Xiaoyun Shen,1 Qiming J. Wang,1 Yongjian Liu,2 Yu Jiang1*
The mammalian target of rapamycin, mTOR, is a central regulator of cell growth. Its activity is regulated by Rheb, a Ras-like small guanosine triphosphatase (GTPase), in response to growth factor stimulation and nutrient availability. We show that Rheb regulates mTOR through FKBP38, a member of the FK506-binding protein (FKBP) family that is structurally related to FKBP12. FKBP38 binds to mTOR and inhibits its activity in a manner similar to that of the FKBP12-rapamycin complex. Rheb interacts directly with FKBP38 and prevents its association with mTOR in a guanosine 5'-triphosphate (GTP)–dependent manner. Our findings suggest that FKBP38 is an endogenous inhibitor of mTOR, whose inhibitory activity is antagonized by Rheb in response to growth factor stimulation and nutrient availability.
1 Department of Pharmacology, University of Pittsburgh School of Medicine, E1357 Biomedical Science Tower, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
2 Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
3 Department of Cell Biology, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.